New drug for stroke prevention approved by NICE

Patients with atrial fibrillation can now be offered dabigatran (Pradaxa) in order to reduce the risk of developing blood clots and subsequent stroke, following final guidance from NICE. Dabigatran should only be offered after a discussion over its risks and benefits in comparison with warfarin.